Concepedia

T. H. Bacon

TH

Statistics

Publications

15

Citations

976

H-Index

13

Active since

1983

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

MRC Clinical Trials Unit at UCL

New Frontier

T. H. Bacon is an author at GlaxoSmithKline (United Kingdom) specializing in life sciences, infectious diseases, and virology.

ORCID

Publications per year

1983–2003

15

Publications

15

Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture

M R Boyd, T. H. Bacon, David Sutton et al. · Antimicrobial Agents and Chemotherapy · 1987 · 238 citations

, , +14

Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus

David L. Earnshaw, T. H. Bacon, Sarah J. Darlison et al. · Antimicrobial Agents and Chemotherapy · 1992 · 233 citations · Full text

, , +16

Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animals

M R Boyd, T. H. Bacon, David Sutton · Antimicrobial Agents and Chemotherapy · 1988 · 114 citations

, , +17

Changes in the populations of lymphoid cells in human peripheral blood following physical exercise.

Andrew J. Edwards, T. H. Bacon, C A Elms et al. · PubMed · 1984 · 81 citations

, , +17

An Overview of the Further Evaluation of Penciclovir against Herpes Simplex Virus and Varicella-Zoster Virus in Cell Culture Highlighting Contrasts with Acyclovir

T. H. Bacon, Raymond F. Schinazi · Antiviral chemistry & chemotherapy · 1993 · 51 citations · Full text

, , +17

1–5 of 15